Latest Software News

Page 43 of 76
Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.
Sophie Babbage
Sophie Babbage
7 Aug 2025
Prophecy International Holdings has agreed to acquire Complexica in a transformative merger, creating Complexica Group Limited, an ASX-listed AI pure play software company with enhanced scale and growth potential.
Sophie Babbage
Sophie Babbage
7 Aug 2025
Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.
Ada Torres
Ada Torres
6 Aug 2025
Infomedia Limited has struck a deal with TPG Capital Asia to be acquired at $1.72 per share, offering shareholders a 41% premium over recent trading prices. The scheme includes fully franked dividends, potentially raising the effective value to $1.74 per share for eligible investors.
Sophie Babbage
Sophie Babbage
6 Aug 2025
Nanoveu Limited advances its proprietary 16nm ECS-DoT chip fabrication, targeting completion by Q4 2025, supported by a strategic partnership and expanded engineering teams across multiple continents.
Sophie Babbage
Sophie Babbage
6 Aug 2025
Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.
Sophie Babbage
Sophie Babbage
5 Aug 2025
Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.
Ada Torres
Ada Torres
5 Aug 2025
Reckon Limited delivered a robust half-year performance in HY25, driven by strong cloud revenue growth and a key acquisition that expanded its SME client base. The company also declared a fully franked dividend, underscoring confidence in its ongoing strategy.
Sophie Babbage
Sophie Babbage
5 Aug 2025
Reckon Limited has reported a robust first half of 2025, marked by significant revenue and profit growth fueled by organic expansion and the acquisition of Cashflow Manager. The company’s cloud-based Reckon One product and US-focused Legal Group continue to drive momentum.
Sophie Babbage
Sophie Babbage
5 Aug 2025
Reckon Limited has delivered a robust half-year performance with a 16% revenue increase and a 29% rise in net profit attributable to members, while declaring a steady fully franked dividend. Despite these gains, the company’s net tangible assets per share remain negative, highlighting ongoing balance sheet pressures.
Sophie Babbage
Sophie Babbage
5 Aug 2025